Login / Signup

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.

Jean Claude Dejon AgobéJean Ronald EdoaYabo Josiane HonkpehedjiJeannot Fréjus ZinsouBayodé Roméo AdégbitèMirabeau Mbong NgweseAnce MangaboulaBertrand LellTamirat Gebru WoldearegaiMartin Peter GrobuschBenjamin MordmüllerAyôla Akim Adegnika
Published in: Parasites & vectors (2019)
The prevalence of schistosomiasis is moderate in communities living in the vicinity of Lambaréné, where a subpopulation with a high risk of reinfection bears most of the burden of the disease. To improve schistosomiasis control in this scenario, we suggest education of these high-risk groups to seek themselves a one-year PZQ treatment. Trial registration clinicaltrials.gov Identifier NCT02769103. Registered 11 May 2016, retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT02769013.
Keyphrases